Image :
Plant Breeding Success stories EdiVite

CPVO 'Plant Breeding Success Stories' continue with another example of a promising enterprise that breaks ground with the first gene-edited vines for wine making in Europe. EdiVite is an Italian spin-off that can be described as a pioneer in production of innovative prototypes for a sustainable viniculture. Today we talk to Mr. Mario Pezzotti who is a full professor in plant genetics at the University of Verona and scientific advisor for EdiVite. In the first part of the interview, we will focus on the creation of EdiVite as a spin-off, the team behind it and the idea of developing genomic-edited vines. 

CPVO: Could you share more about the founding process of EdiVite as a spin-off? What motivated the establishment of this venture?  

EdiVite: EdiVite is a university spin-off originating from the Agricultural Genetics laboratory of Mario Pezzotti and Sara Zenoni, in collaboration with viticulturists Marianna Fasoli and Giovanni Battista Tornielli, and plant pathologist Annalisa Polverari. The initiative was driven by a diverse group of entrepreneurs, including farmers, nursery owners, and agri-risk insurance professionals. The primary motivation was to address the need for genetic innovation in viticulture, using genome editing to enhance disease resistance in elite grapevine varieties.   

CPVO: How many people currently work at EdiVite, and what are the main professional profiles and roles within the team?  

EdiVite: We currently have two full-time employees, one PhD student, and five internship students. The team primarily consists of plant biotechnologists and viticulturists, with ongoing supervision provided by the academic founders of the spin-off.   

EdiVite vines

CPVO: What expertise was considered essential when building the team, especially given the technical and regulatory challenges in genomic editing?  

EdiVite: In this initial phase, EdiVite focuses on producing plant prototypes, so the team was assembled with expertise in plant tissue culture, genetics, genomics, bioinformatics, plant pathology, and viticulture. These skills were deemed critical to achieving the project's technical objectives.   

CPVO: How does EdiVite plan to grow its team in the future to support new projects and collaborations?  

EdiVite: We plan to expand our team by recruiting experts in management, finance, and human resources to support the transition from a spin-off to a small enterprise. This growth will enable the company to attract financial investments and facilitate the commercialization of genetically edited grapevines resistant to downy and powdery mildews.   

CPVO: What were the main technical and regulatory challenges encountered during the development and implementation of genetically edited vines? 

EdiVite: From a technical perspective, assembling the expertise required to regenerate plants from single protoplasts and optimizing conditions for DNA-free editing via protoplast transfection was particularly challenging. On the regulatory side, the team benefited from the updated Italian legislation (July 22, 2023), which eased restrictions and allowed scientists to request authorization for experimental trials. However, aligning their work with the requirements of the 2001/18 European Directive posed initial difficulties in understanding and meeting all regulatory criteria. 

EdiVite vines

CPVO: What are the prospects for applying NGTs (New Genomic Techniques) to other vine varieties, and what is the expected timeline for these developments?

EdiVite: Tissue culture conditions and protoplast regeneration have already been optimized for around a dozen national and international grapevine varieties. The necessary pipeline is in place; the next steps involve conducting additional experiments, establishing more experimental fields, and registering the clones once European regulations permit. We are optimistic about progress and hope for a supportive regulatory environment to accelerate these developments.   

CPVO: How do you assess the acceptance among winemakers and consumers regarding the use of vines obtained through genomic editing? 

EdiVite: We actively engage in outreach with farmers, enologists, policymakers, and wine organizations, and we’ve observed positive responses within the wine industry. There is strong interest in environmental and economic sustainability, which aligns with these advancements. Consumers are increasingly aware of the wine sector’s efforts to adapt to climate change and enhance sustainability, which can foster broader acceptance.   

CPVO: Which collaborations with research institutions or wine industry companies have been crucial to the success of the project?

EdiVite: We have established collaborations with various global partners, including universities, research institutions such as INRAE, CREA, and industry leaders like Gallo. These partnerships have been instrumental in advancing our research and innovation.   

CPVO: How does EdiVite address the challenges related to intellectual property protection for grapevine varieties obtained through NGTs?

EdiVite: This remains a complex issue, particularly given the current uncertainty in European regulations. The framework for intellectual property protection is still under discussion and requires greater clarity.